About Array BioPharma Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, ... Aston Martin falls 5% in its London IPO. Phone Number 303.381.6600 Array BioPharma is a biopharmaceutical company that focuses on the development and commercialization of small molecule drugs to treat patients afflicted with cancer and other high-burden diseases. All times are ET. Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer. Array BioPharma closed the underwritten public offering of 24,069,766 shares of the Boulder-based company's common stock, which includes 3,139,534 shares of common stock issued upon the exercise in full of the option to purchase additional shares granted to the underwriters, at a public offering price of $10.75 per share. Array BioPharma Inc. operates as a discovery research company creates drug candidates. ARRY chart by TradingView IPO Boutique aggregates information on public companies and private companies, such as "ARRY" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. Array BioPharma Inc. ist ein Unternehmen aus den Branchen Biotechnologie und Pharma aus den USA. Disclaimer.
Consumer healthcare sales fell 3% to $862 billion. This firm is working on late-stage clinical programs with modest expectations. Array BioPharma is a biopharmaceutical company that focuses on the development and commercialization of small molecule drugs to treat patients afflicted with cancer and other high-burden diseases. Unternehmen aus der Peer Group von Array BioPharma Inc. ist EVOTEC SE. For IPO Boutique's "scale of 1 to 5" BUY rating on Array Biopharma, and our comprehensive analysis, click "Buy Market Research ". Array may also use a portion of the net proceeds to acquire or invest in complementary businesses, technologies, drugs, drug candidates or other intellectual property, although it has no present commitments or agreements to do so. ARRY: Get the latest Array BioPharma stock price and detailed information including ARRY news, historical charts and realtime prices. ARRAY BIOPHARMA (580564 | US04269X1054) mit aktuellem Aktienkurs, Charts, News und Analysen. Array BioPharma has 298 employees across 9 locations and $173.77 M in annual revenue in FY 2018. The company is a subsidiary of Pfizer. Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. Array BioPharma was founded on 1998 and is headquartered in Boulder, Colorado.Array BioPharma is a biopharmaceutical company focused on the development and commercialization of targeted small molecule drugs. Morningstar: © 2018 Morningstar, Inc. All Rights Reserved. Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule … Barnes & Noble stock soars 20% as it explores a sale. Array BioPharma is a U.S.-based, clinical stage, pharmaceutical company that focuses on oncology medication. Tony Piscopio, Kevin Koch, David Snitman, and K.C. Array BioPharma Inc. (ARRY:NASDAQ) Array BioPharma Inc. (ARRY:NASDAQ) has a market of $565M. All rights reserved. Factset: FactSet Research Systems Inc. 2018. Array's binimetinib is currently being developed for ovarian cancer and melanomas, but combinations provide for a long-lived pipeline. Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. Nicolaou. Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer. See insights on Array BioPharma including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft. Standard & Poor's and S&P are registered trademarks of Standard & Poor's Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. Array BioPharma Inc. ist ein Unternehmen aus den Branchen Biotechnologie und Pharma aus den USA. All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2018 and/or its affiliates. Unternehmen aus der Peer Group von Array BioPharma Inc. ist EVOTEC SE. Keine Analysen im Zeitraum eines Jahres in dieser Kategorie verfügbar.Um Ihnen die Übersicht über die große Anzahl an Nachrichten, die jeden Tag für ein Unternehmen erscheinen, etwas zu erleichtern, haben wir den Nachrichtenfeed in folgende Kategorien aufgeteilt:Online Brokerage über finanzen.netWählen Sie eine Produktart, um auf die ausführliche Suche weitergeleitet zu werden.Oskar ist der einfache und intelligente ETF-Sparplan.